A compelling and cheap investment
At first sight, this professional services business appears a decent investment story, but not a compelling one, says Max King. Yet dig a little deeper and it looks much better.
At first sight, Law Debenture (LSE: LWDB) appears a decent investment story but not a compelling one. Yet dig a little deeper and it looks much better. LWDB is a curious hybrid: a professional-services business tacked onto an investment portfolio. The former accounts for slightly more than 13% of net asset value (NAV the value of the underlying portfolio); the latter is 75% invested in UK equities.
The shares trade on a near-10% discount to NAV and yield 3.2%, helped by the professional-services business accounting for about 40% of the pay-out. The investment record, a 58% return over five years and 36% over three, is decent, but well below its peers in the global sector of investment trusts. So why are the shares worth a look?
A generous dividend
The dividend is already generous, but the recent decision to allocate 75% of investment-management and interest costs to capital will add 20% to earnings, enabling a further rise. The potential increase of 35% will not happen all at once, but investors can expect dividend growth at least in line with the 9.2% of 2018 rather than the average of 4.5% of the last ten years. This dividend growth will be further enhanced by the accelerated growth in the professional-services business and in the income from the investment portfolio.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The portfolio is managed by Janus Henderson at a cost of just 0.3% of NAV (the total ongoing charges of LWDB are only 0.43%). For this modest cost, LWDB gets a first-rate team the highly regarded veteran James Henderson and rising stars Laura Foll and Charlotte Greville. Their portfolio, £663m at the start of the year, is invested in about 130 stocks, of which the top-ten account for 24%.
About a third of the UK portfolio is in the FTSE 100, the rest mostly in mid caps. As in their other portfolios, the allocation to industrials is high but to consumer sectors low. A rising allocation to financial services, including the recently bought RBS and Direct Line, shows a contrarian streak.The team is happy with the high UK weighting, seeing it as a value opportunity. If this comes to bear, high UK exposure should no longer be a handicap to performance.
The professional-services business, established 130 years ago, provides advice, administration and management for pension funds, corporate trusts and other company entities, usually fulfilling a role stipulated by law. For seven years, the business marked time, but both revenue and earnings jumped by 9% in 2018. According to chief executive Denis Jackson, "clients loved us but shareholders were disappointed." He saw a need to market more, developing better relationships with banks and boutique financial businesses, as well as withlaw firms.
Strong growth ahead
Growth is not reflected in a valuation of less than ten times earnings, nearly all of which can be distributed as dividends. A more realistic valuation would add 50p to NAV per share, increasing the discount of the shares to 15%. At present, the valuers are cautious, but that will change when growth is confirmed rather than projected. These shares are a bargain.
Activist watch
Yet Barclay's doesn't need "a hostile disruptor in its midst, arguing on false numbers against their execution of the existing strategy to improve returns, for his own short-term ends", says Merian. Aviva Investors' David Cumming, who has previously backed Bramson, has also said he would side with Barclays. The bank has accused Bramson of being "selective and misleading" in his description of the struggling investment banking arm.
Short positions...Woodford's offshore blip
Yet the sector's new watchdog, the Regulator for Social Housing, has issued a string of negative judgements against the governance and financial failings it found in some of the housing associations to whom the funds lease properties. Civitas shares have "slumped" 11% since the regulator's report was published on 4 April, while Triple Point has fallen 10%.
Three of Neil Woodford's stakes in unquoted private companies were suspended from the Guernsey stock exchange last Thursday, says Kate Beioley in the Financial Times. Over the past ten months the fund manager has listed his stakes in biotech company Benevolent AI, cold-fusion company Industrial Heat and technology investor Ombu offshore in an effort to keep the portfolio of his equity-income fund below the regulatory limit for unquoted stocks.
Stocks are usually suspended if "there are question marks over whether they have complied with the exchange's listing rules". Although the suspension may affect the fund's unquoted threshold, it has no immediate impact on the investments within the fund.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published